← SynDRA
CP1-1189
SynDRA canonical compound SYN0039526 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | TNF |
|---|
| Mechanism of action | Tumor necrosis factor release inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- Tumor necrosis factor release inhibitor
Cross-references
Synonyms
- CPI-1189
- REN-1654
- Antineurodegeneratives, Centaur
- CPI-1160
- Parkinsons therapy, Centaur
- REN-1189
- Cpi 1189
- N-tert-butyl-4-acetamidobenzamide
- 9JX1L8VH4Z
- Benzamide, 4-(acetylamino)-N-(1,1-dimethylethyl)-
- RefChem:919143
- DTXCID8093946
- 4-acetamido-n-(tert-butyl)benzamide
- 4-Acetamido-N-tert-butylbenzamide
- MFCD00774476
- UNII-9JX1L8VH4Z
- Oprea1_675160
- LU 02-584
- 4-(Acetylamino)-N-(1,1-dimethylethyl)benzamide
- SCHEMBL154117
- orb1304060
- SCHEMBL1176804
- 4-acetamido-N-tert-butyl-benzamide
- EBC-12070
- s2465
- STK087738
- 4-(acetylamino)-N-tert-butylbenzamide
- AKOS003267462
- CPI1189(REN-1189)?
- REN 1654, REN 1189
- NCGC00241114-01
- AS-35332
- SY242192
- DB-119967
- HY-100376
- CS-0018704
- NS00068140
- T3561
Look up CP1-1189 in the interactive SynDRA portal →